醫(yī)生介紹
邵鵬飛,男,副主任醫(yī)師,醫(yī)學(xué)博士,泌尿外科創(chuàng)新團(tuán)隊骨干成員。專業(yè)方向為泌尿系統(tǒng)腫瘤的診斷及微創(chuàng)治療,有豐富的腹腔鏡腫瘤治療經(jīng)驗。擅長腹腔鏡下前列腺癌根治術(shù)、腹腔鏡下腎癌根治術(shù)、腹腔鏡下腎部分切除術(shù)、腹腔鏡下膀胱癌根治術(shù)和尿流改道術(shù)等各類腫瘤微創(chuàng)手術(shù)。獲江蘇省科學(xué)技術(shù)一等獎1項,衛(wèi)生廳新技術(shù)引進(jìn)獎一等獎1項,主持國家自然科學(xué)基金1項,腎癌、膀胱癌、前列腺癌等微創(chuàng)治療的研究論文發(fā)表在歐洲泌尿外科雜志、英國泌尿外科雜志,中華外科雜志、中華泌尿外科雜志等國內(nèi)外權(quán)威雜志上。 【科研項目】國家自然科學(xué)基金:PLA2G7在前列腺癌中的表達(dá)和調(diào)控機制【獲獎成果】2013年江蘇省科學(xué)技術(shù)一等獎2013年江蘇省衛(wèi)生廳新技術(shù)引進(jìn)一等獎2012年江蘇省衛(wèi)生廳新技術(shù)引進(jìn)二等獎【發(fā)表文章】1. Zhu C, Shao P, Bao M, Li P, Zhou H, Cai H, Cao Q, Tao L, Meng X, Ju X, Qin C, Li J, Yin C. miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. Urol Oncol. 2013,In press.2. Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao L, Cai H, Li P, Cao Q, Ju X, Meng X, Qin C, Hua L, Shao P, Yin C. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines. Prostate. 2013, In press.3. Cao Q, Ju X, Li P, Meng X, Shao P, Cai H, Wang M, Zhang Z, Qin C, Yin C. A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk. PLoS One. 2012;7(11):e50302.4. Shao P, Tang L, Li P, Xu Y, Qin C, Cao Q, Ju X, Meng X, Lv Q, Li J, Zhang W, Yin C. Application of a Vasculature Model and Standardization of the Renal Hilar Approach in Laparoscopic Partial Nephrectomy for Precise Segmental Artery Clamping. Eur Urol. 2012, In press.5. Chen J, Shao P, Cao Q, Li P, Li J, Cai H, Zhu J, Wang M, Zhang Z, Qin C, Yin C. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One. 2012;7(7):e40817.6. Shao P, Tang L, Li P, Xu Y, Qin C, Cao Q, Ju X, Meng X, Lv Q, Li J, Zhang W, Yin C. Precise Segmental Renal Artery Clamping Under the Guidance of Dual-source Computed Tomography Angiography During Laparoscopic Partial Nephrectomy. Eur Urol. 2012;62(6):1001-8.7. Chen J, Wu Y, Shao P, Cao Q, Qin C, Li P, Ding Q, Zhu J, Wang M, Zhang Z, Li J, Yin C. Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese. DNA Cell Biol. 2012;31:790-6.8. Shao P, Ding Q, Qin C, Wang M, Tang J, Zhu